Diabetes - Nursing Case Study
Pathophysiology
• Primary mechanism: In Type 1 Diabetes, the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency and elevated blood glucose levels.
• Secondary mechanism: In Type 2 Diabetes, insulin resistance occurs where body cells do not respond effectively to insulin, often exacerbated by obesity. This leads to increased insulin demand, beta cell dysfunction, and eventually relative insulin deficiency.
• Key complication: Chronic hyperglycemia damages blood vessels, leading to complications such as retinopathy, nephropathy, and neuropathy, significantly impacting patient quality of life and increasing morbidity.
Patient Profile
Demographics:
58-year-old female, high school teacher
History:
• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia
• Current medications: Metformin 1000 mg twice daily, Lisinopril 10 mg daily, Atorvastatin 20 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing fatigue and blurry vision
• Key symptoms: Numbness in feet, frequent urination, occasional dizziness
• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 210 mg/dL
Section 1
Upon further assessment, the patient exhibits significant signs of diabetic neuropathy, as evidenced by the numbness and tingling in her feet, which raises concerns about her ability to detect injuries or ulcers. Given her blurred vision, a comprehensive eye examination is conducted, revealing early signs of diabetic retinopathy, a common complication due to prolonged hyperglycemia. The retinal examination shows microaneurysms and mild retinal hemorrhages, indicative of retinal damage that could progress if blood glucose levels are not controlled more effectively.
In addition to the neurological and ocular findings, the patient's laboratory results indicate a concerning trend in her renal function. Her latest serum creatinine level is 1.4 mg/dL, slightly elevated from previous readings, and her estimated glomerular filtration rate (eGFR) has decreased to 55 mL/min/1.73 m², suggesting early-stage diabetic nephropathy. Urinalysis reveals microalbuminuria, further confirming renal involvement. This constellation of findings underscores the need for enhanced glycemic control and potential medication adjustments to prevent further progression of these complications.
The nursing team is tasked with implementing a comprehensive care plan focusing on patient education, emphasizing the importance of blood glucose monitoring, adherence to prescribed medications, and lifestyle modifications, including diet and exercise. Additionally, a referral to a nephrologist and an ophthalmologist is recommended to address the emerging complications more thoroughly. The patient is also counseled on the importance of foot care to prevent infections or injuries, given the risk posed by her neuropathy. This coordinated approach aims to stabilize her condition and prevent further deterioration, setting the stage for evaluating her response to these interventions in subsequent follow-ups.
Section 2
As the nursing team implements the comprehensive care plan, the patient demonstrates a diligent commitment to monitoring her blood glucose levels and adhering to her medication regimen. During a follow-up visit two months later, the patient reports maintaining a more consistent blood glucose range, with her home readings generally between 100-140 mg/dL. She has also made significant dietary changes, reducing her carbohydrate intake and incorporating more fiber-rich foods, which has contributed to a modest weight loss of 5 pounds. Her daily walking routine has increased to 30 minutes, five times a week, showing her dedication to lifestyle modifications.
Despite these positive changes, the patient presents with a new set of symptoms during the follow-up visit. She reports a persistent dry cough and mild shortness of breath on exertion, which have been gradually worsening over the past three weeks. Her vital signs reveal a blood pressure of 138/82 mmHg, heart rate of 88 beats per minute, respiratory rate of 20 breaths per minute, and an oxygen saturation of 95% on room air. Given these respiratory symptoms, along with her history of diabetes and potential complications, the healthcare team decides to investigate further to rule out any underlying cardiovascular issues or pulmonary complications.
A chest X-ray and an echocardiogram are ordered to assess her cardiac and pulmonary status. The chest X-ray reveals mild bilateral interstitial markings, suggestive of early congestive heart failure, a common comorbidity in diabetic patients. The echocardiogram shows a slightly reduced ejection fraction of 45%, indicating compromised cardiac function. These findings necessitate a re-evaluation of her cardiovascular risk factors and prompt collaboration with a cardiologist to optimize her management plan. This development underscores the complexity of managing diabetes and its complications, highlighting the need for ongoing monitoring and adaptation of the patient's care strategy to address emerging health issues comprehensively.
Section 3
Following the findings from the chest X-ray and echocardiogram, the healthcare team decides to initiate a more intensive cardiovascular management plan for the patient. The cardiologist recommends starting the patient on a low-dose ACE inhibitor to help manage her blood pressure and improve cardiac function. Additionally, a diuretic is prescribed to address fluid retention, which may be contributing to her mild shortness of breath. The patient's medication regimen is adjusted, and she is advised to monitor her blood pressure at home, alongside her regular blood glucose checks.
In the weeks following these adjustments, the patient reports some improvement in her symptoms. Her cough has become less frequent, and she experiences less shortness of breath during her daily activities. However, during a routine follow-up appointment, there is a new concern: the patient complains of increasing fatigue and occasional dizziness, particularly when standing up quickly. Her blood pressure readings at home have shown a trend toward lower values, often around 110/70 mmHg, which raises the possibility of orthostatic hypotension induced by her medication changes.
These developments prompt the healthcare team to reassess her treatment plan, focusing on balancing the management of her cardiovascular symptoms with maintaining adequate blood pressure levels. It becomes crucial to educate the patient on recognizing signs of hypotension and ensuring she takes measures to prevent falls. The team discusses potential adjustments in her diuretic dosage and considers non-pharmacological approaches, such as dietary modifications to ensure adequate fluid and electrolyte intake. This stage in the patient's journey emphasizes the dynamic nature of managing diabetes and its complications, requiring a vigilant approach to adapting the care plan to ensure optimal outcomes.
Section 4
In the subsequent weeks, the patient's condition evolves, bringing new challenges for the healthcare team. During a routine clinic visit, the patient presents with increased fatigue and reports occasional episodes of palpitations. A focused assessment reveals her heart rate is elevated, averaging around 95 beats per minute at rest. Additionally, her blood pressure remains on the lower end, registering at 108/68 mmHg, suggesting that the diuretic and ACE inhibitor combination may need further refinement. Blood tests are ordered to evaluate her electrolytes, given the potential impact of diuretics on potassium levels and overall fluid balance.
The laboratory results indicate a mild hypokalemia, with her serum potassium level at 3.2 mmol/L, which could be contributing to her fatigue and palpitations. Her fasting blood glucose levels have also remained within the target range, albeit with occasional dips into hypoglycemia, which could further complicate her cardiovascular symptoms. These findings prompt the healthcare team to consider adjusting her diuretic therapy, perhaps opting for a potassium-sparing alternative or supplementing with oral potassium.
Given these developments, the healthcare team engages in a multidisciplinary discussion to refine her treatment strategy. They emphasize the importance of patient education, particularly regarding dietary intake rich in potassium, such as bananas and leafy greens, and maintaining adequate hydration. The team also explores the potential need for a Holter monitor to assess for any underlying arrhythmias, which may be contributing to her palpitations and fatigue. Through these targeted interventions and ongoing monitoring, the team aims to optimize her cardiovascular stability while managing her diabetes, ensuring a balanced approach to her complex health needs.
Section 5
In the following weeks, the patient's condition necessitates a closer examination due to new developments. During a follow-up visit, she reports experiencing increased frequency of palpitations, now accompanied by dizziness and intermittent shortness of breath. A focused cardiovascular assessment reveals a resting heart rate that has increased to 105 beats per minute, while her blood pressure remains relatively stable at 110/70 mmHg. The patient also describes a noticeable decrease in exercise tolerance, which prompts the healthcare team to delve deeper into the potential causes of her symptoms.
The decision to employ a Holter monitor proves insightful, as the 24-hour ECG recording reveals frequent premature ventricular contractions (PVCs) and occasional short runs of ventricular tachycardia. These arrhythmic episodes correlate with the patient's reported palpitations and dizziness, highlighting a potential link to her hypokalemia. A repeat blood test confirms persistent hypokalemia with a serum potassium level of 3.1 mmol/L, despite dietary modifications and initial potassium supplementation. Consequently, the team considers the need to discontinue the current diuretic in favor of a potassium-sparing alternative to mitigate further electrolyte imbalances.
In light of these findings, the healthcare team opts to initiate a low-dose spironolactone therapy while continuing to educate the patient on dietary potassium sources and the importance of adherence to her medication regimen. They also schedule a follow-up visit to reassess her electrolyte levels and cardiovascular status. This strategic adjustment aims to stabilize her potassium levels, reduce the frequency of arrhythmias, and consequently alleviate her symptoms. As the team monitors the patient's response to the interventions, they remain vigilant for any further complications that might arise, ensuring a comprehensive and dynamic approach to her ongoing care.